Back to PFE Stock Lookup

PFE – FDA

Apr 22, 2014 08:01 AM Pfizer, Inc. (PFE) Reports Statistically Significant Data from Two OPT Program Phase 3s
Apr 17, 2014 08:44 AM Teva Pharma (TEVA), Pfizer (PFE) Settle Over Generic Celebrex
Apr 10, 2014 06:16 AM Pfizer (PFE), Acura Pharma (ACUR) Terminate AVERSION Technology License
Apr 7, 2014 05:57 AM Pfizer (PFE) Reports PALOMA-1 Met Primary Endpoint in Phase 2
Apr 1, 2014 10:40 AM Cubist Pharma (CBST) SIVEXTRO Approval Outlook Improves; Aegis Maintains 'Buy' Rating
Mar 27, 2014 08:02 AM Pfizer (PFE) Reports Bococizumab Met Primary Endpoint in Phase 2b
Mar 26, 2014 08:01 AM Pfizer (PFE) Reports GENOTROPIN Met Primary Endpoint in Phase 3B
Mar 25, 2014 08:39 AM Pfizer Inc. (PFE) Reports XALKORI Phase 3 Met Primary Endpoint in NSCLC
Mar 20, 2014 08:31 AM Pfizer's (PFE) Bivalent rLP2086 Granted FDA Breakthrough Designation
Mar 14, 2014 01:04 PM Bristol-Myers (BMY), Pfizer (PFE) Report FDA Approval of Eliquis sNDA
Mar 13, 2014 06:32 AM Mylan (MYL) Issues Commentary on Favorable Celebrex Decision (PFE)
Mar 12, 2014 06:39 AM Pfizer (PFE) Reports Prevenar 13 Met Primary, Secondary Objectives in CAPTA
Feb 24, 2014 07:02 AM Pfizer(PFE) CAPiTA Met Primary, Secondary Objectives
Feb 14, 2014 12:03 PM Mylan (MYL) Unit Launches Recall on Etomidate Injection
Feb 11, 2014 02:04 PM Pfizer (PFE) Agrees with FDA Committed on Naproxen vs. NSAIDs as Cardiovascular;ar Risk
Feb 5, 2014 06:53 AM Pfizer (PFE), Merck (MRK) Enter Collaboration to Explore MK-3475 Therapeutic Potential
Feb 3, 2014 10:19 AM Pfizer (PFE) Likely to Approach FDA about Palbociclib NDA Filing; Goldman Comments
Feb 3, 2014 07:01 AM Pfizer (PFE) Palbociclib Phase 2 Met Primary Endpoint
Jan 27, 2014 07:02 AM Pfizer (PFE) Dacomitinib Phase 3 Misses PFS Improvement Objective
Jan 23, 2014 08:02 AM Pfizer (PFE) Reports ALO-02 Met Primary Endpoint in Phase 3
Jan 13, 2014 08:17 AM Portola Pharmaceuticals (PTLA) Enters Second Collaboration Deal with Bristol-Myers (BMY)
Jan 7, 2014 02:30 PM Mylan (MYL) Begins Sales of Generic Detrol LA (PFE)
Jan 3, 2014 08:33 AM Teva Pharma (TEVA) Reports Launch of Generic Detrol LA
Dec 19, 2013 05:02 PM Bristol-Myers (BMY), Pfizer (PFE) sNDA for ELIQUIS Approved by FDA
Dec 18, 2013 09:42 AM Mylan (MYL) Approved to Acquire Pfizer's LAMA Compound
Dec 17, 2013 11:57 AM Pfizer (PFE), Teva (TEVA) Enter Settlement Over Viagra Patent
Dec 12, 2013 07:08 AM Lpath (LPTN) Pulls From iSONEP Bidding (PFE)
Nov 21, 2013 11:03 AM BioMarin (BMRN) May Draw Interest Following Recent FDA Panel Vote (PFE) (RHHBY)
Nov 21, 2013 11:01 AM Pfizer's (PFE) XALKORI Receives FDA Approval as NSCLC Treatment
Nov 18, 2013 04:48 PM Pfizer (PFE) sNDA for XELJANZ Receives U.S. FDA Approval
Nov 8, 2013 08:02 AM Pfizer (PFE) Reports RAPAMUNE Did Not Meet Primary Endpoint in Phase 3B/4
Nov 4, 2013 05:15 PM Pfizer (PFE) Receives FDA Approval for EMBEDA Prior Approval Supplement
Oct 23, 2013 04:58 PM Pfizer (PFE), Pain Therapeutics (PTIE) Amend REMOXY Pact
Oct 22, 2013 08:12 AM DURECT Corp (DRRX) Reports Continued Development of REMOXY (PFE)
Oct 22, 2013 08:06 AM Pain Therapeutics (PTIE) Said Pfizer (PFE) to Continue to Develop REMOXY
Oct 18, 2013 08:04 AM Pfizer (PFE) Reports Lyrica Met Primary Endpoint in Phase 3b Trials
Oct 17, 2013 07:05 AM Pfizer (PFE) Receives Additional Indication for Prevenar 13 in Europe
Oct 8, 2013 04:51 PM Lpath (LPTN) Reports Pfizer (PFE) to Divest Assets; Proposes to Sell iSONEP
Oct 3, 2013 04:15 PM Pfizer (PFE) Affirms FDA Approval of Duavee (LGND)
Oct 3, 2013 03:52 PM Ligand Pharma (LGND) Up as Hot-Flash, Osteoporosis Drug Duavee Get FDA Approval (PFE)
Sep 30, 2013 02:51 PM PDUFA, FDA Panel Review Dates at Risk with Gov't Shutdown (AMRN) (LGND)
Sep 30, 2013 07:31 AM Mylan (MYL) Launches Generic VFEND (PFE)
Sep 27, 2013 11:39 AM FDA Says Pfizer's (PFE) IV Tygacil Leads to Increased Risk of Death
Aug 16, 2013 12:34 PM Pain Therapeutics (PTIE), Durect (DRRX) Higher on Remoxy News (PFE)
Aug 13, 2013 03:23 PM Novartis (NVS), Pfizer (PFE) Out on Onyx (ONXX); Is Amgen (AMGN) the Sole Runner?
Aug 12, 2013 10:24 AM Risk/Reward for Isis Pharma (ISIS) is Sinking Fast - Barron's
Jul 30, 2013 06:23 AM Pfizer, Inc. (PFE) Tops Q2 EPS by 1c; Reports Solid Emerging Market Gains
Jul 29, 2013 06:15 AM Pfizer (PFE) Will Provide Additional Prevenar 13 to GAVI Alliance
Jul 25, 2013 05:10 PM CHMP Affirms Recommendation Against Approving Pfizer (PFE) XELJANZ as RA Treatment
Jul 22, 2013 12:33 PM Amgen (AMGN) Still Interested in Onyx (ONXX) as Pfizer (PFE), Novartis (NVS) Circle

Back to PFE Stock Lookup